Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 3, 2021
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
Jeffrey Hung Maintained (VYGR) at Hold with Decreased Target to $7 on, Feb 3rd, 2021
Jeffrey Hung of Morgan Stanley, Maintained "Voyager Therapeutics, Inc." (VYGR) at Hold with Decreased Target from $13 to $7 on, Feb 3rd, 2021.
Jeffrey has made no other calls on VYGR in the last 4 months.
There are 2 other peers that have a rating on VYGR. Out of the 2 peers that are also analyzing VYGR, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, November 11th, 2020
This is the rating of the analyst that currently disagrees with Jeffrey
- Reni Benjamin of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $17 on, Tuesday, November 10th, 2020
